Small Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Small Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy
This clinical trial update reports on refractoriness to ibrutinib, a Bruton Tyrosine Kinase inhibitor, and to systemic targeted therapies in…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Phase 2 study evaluating ibrutinib as early therapy for chronic lymphocytic leukemia and small lymphocytic leukemia; the trial is completed …
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL [Phase 1, Phase 2]
Phase 1/2 trial of MT-3724 in relapsed or refractory diffuse large B-cell lymphoma and related B-cell hematologic malignancies; the study is…
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Duvelisib for Ibrutinib-Resistant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial of duvelisib in ibrutinib-resistant CLL/SLL was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia [Phase 1]
A Phase I dose-escalation study of CAT-8015 (moxetumomab pasudotox) in participants with chronic leukemia; the trial was terminated and resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-27Clinical Trial Update: Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL [Phase 1]
A Phase 1 dose-escalation study of lenalidomide (Revlimid) with fludarabine-rituximab in patients with chronic lymphocytic leukemia and smal…